Researcher Hopes Vaccines Can Improve Immunotherapy Outcomes in RCC – OncLive
OncLive |
Researcher Hopes Vaccines Can Improve Immunotherapy Outcomes in RCC
OncLive Certainly, there have been several lost causes that we've seen thus far, but as we get better at designing vaccines, hopefully this is a step forward in improving immunotherapy for kidney cancer,” says Zhang. In an interview with OncLive at the 2016 … |
